Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$3,086,646
-$255,463 QoQ
Shares Held
128,183
+7.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#784
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fulton Bank, N.A. holds $64,915,903 across 12 Drug Manufacturers - General names. PFE ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,349 | $17,210,622 | |
| 2 | ABBV |
AbbVie Inc.
|
52,406 | $13,187,445 | |
| 3 | MRK |
Merck & Co., Inc.
|
80,029 | $10,283,726 | |
| 4 | JNJ |
Johnson & Johnson
|
32,005 | $8,128,309 | |
| 5 | AMGN |
Amgen Inc
|
14,713 | $5,327,871 | |
| 6 | PFE |
Pfizer Inc
This page
|
128,183 | $3,086,646 | |
| 7 | SNY |
Sanofi
|
68,196 | $2,909,240 | |
| 8 | AZN |
Astrazeneca PLC
|
8,294 | $1,572,707 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,086,646 | 128,183 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,342,109 | 119,021 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,933,169 | 117,798 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $2,973,158 | 116,686 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,418,182 | 99,760 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $2,024,868 | 79,908 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,574,576 | 97,044 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $3,625,660 | 125,282 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,248,309 | 116,094 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $3,058,576 | 110,219 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $4,987,550 | 173,239 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $5,845,846 | 176,239 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $6,171,335 | 168,248 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $6,571,492 | 161,066 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $7,182,412 | 140,172 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $5,952,278 | 136,021 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $6,947,865 | 132,517 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $7,273,529 | 140,497 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $8,546,188 | 144,728 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $7,231,485 | 168,135 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $7,073,901 | 180,641 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $6,250,471 | 172,522 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $6,306,729 | 171,332 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $6,414,419 | 174,780 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $5,381,803 | 164,581 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $5,484,458 | 168,029 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||